Mass production process of polycrystalline high-content benzoic acid alogliptin

A mass production, benzoic acid technology, applied in the preparation of carboxylate, organic chemistry and other directions, can solve the problems of difficult removal, unavoidable, affecting the purity of finished products, etc., to achieve the effects of easy removal, low price and high yield

Inactive Publication Date: 2013-08-14
合肥拓锐生物科技有限公司
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] Starting with 6-chloro-3-methyluracil, although impurities are avoided However, when introducing the (R)-3-aminopiperidine substituent group, (R)-3-aminopiperidine dihydrochloride is also us...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mass production process of polycrystalline high-content benzoic acid alogliptin
  • Mass production process of polycrystalline high-content benzoic acid alogliptin
  • Mass production process of polycrystalline high-content benzoic acid alogliptin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0032] Alogliptin can be prepared by the method provided by CN101360723A, and benzoic acid is commercially available analytically pure from Shanghai Suyi Chemical Reagent Co., Ltd.

[0033] Get benzoic acid 5kg, put 200 liters of reactors, add 100 liters of pure water, stir and heat up and reflux for 1 hour. The temperature of the reaction solution was lowered to 55-60°C, centrifuged, and the filter cake was air-dried at 60-65°C for 10-12 hours to obtain 2.41 kg of refined white needle-shaped benzoic acid (HPLC: 99.9%); yield: 48.2%.

[0034] 2 Preparation of alogliptin benzoate:

[0035] Take 3.11kg of alogliptin (HPLC: 99.6%) and 1.13kg of refined benzoic acid, and put them in a 50-liter reaction kettle. Add 15L of ethanol, heat to dissolve, heat to reflux for 2 to 3 hours, a white solid precipitates out. Stop heating, naturally cool to room temperature, stir and crystallize for 10-12 hours. After centrifugation, the solid was washed with 1 liter of ethanol and air-dried...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a mass production process of polycrystalline high-content benzoic acid alogliptin. According to the process, the products do not need to be refined and the qualified products conforming to the pharmaceutical production demand can be obtained directly. The process comprises the following steps: putting 5kg of the benzoic acid into a 200L reaction kettle; adding 100L of pure water; stirring, heating and refluxing for 1 hour; centrifuging after the reaction liquid is decreased to 50 to 60 DEG C; filtering into a filter cake in a pressing manner by using a plate-and-frame filter press and performing the forced air drying at the temperature of 60 to 65 DEG C for 10 to 12 hours, thereby obtaining 2.41kg of a white needle-shaped crystal benzoic acid refined product; putting 3.11kg of alogliptin and 1.13kg of the white needle-shaped crystal benzoic acid refined product into the reaction kettle; adding 15L of a solvent; heating and dissolving; heating until refluxing for 2 to 3 hours; stopping the heating until separating out white solids; naturally cooling to the room temperature; stirring and separating out a crystal for 10 to 12 hours; centrifuging; washing the obtained solid by using 1L of the solvent; and performing the forced air drying for 8 to 10 hours at the temperature of 40 to 45 DEG C, thereby obtaining 3.82kg of the finished polycrystalline high-content benzoic acid alogliptin product.

Description

【Technical field】 [0001] The invention relates to a batch production process of polymorphic high-content alogliptin benzoate. The product does not need to be further refined, and qualified products meeting the requirements of pharmaceutical production can be directly obtained. 【Background technique】 [0002] Alogliptin is a selective serine protease dipeptidyl peptidase IV (DPP IV) inhibitor, through the control of glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP, also known as It is the incretin activity of gastric inhibitory peptide), which can effectively maintain blood sugar homeostasis (glucose homeostasis, glucose homeostasis). Therefore, it has been proposed as a powerful drug in the treatment of type 2 diabetes. The benzoate salt of alogliptin (SYR-322) has shown encouraging antidiabetic efficacy. [0003] Alogliptin is chemically named 2-[6-[3(R)-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydro Pyrimidin-1-ylmethyl]b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C63/06C07C51/41C07D401/04
Inventor 陆文通
Owner 合肥拓锐生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap